GASKINS TAMMI L (Chief Commercial Officer) sold 9.1% of their position (21.53K shares) of IRONWOOD PHARMACEUTICALS INC on the open market
Open‑market sale worth $80.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 2/25/2026ACC: 0001193125-26-071500
Officer· Chief Commercial Officer
Since Feb 2026
-21.53K
Net shares
Net seller
$80.3K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
21.53K disposed
Non-Derivative Transactions2
Class A Common Stock
Direct
Shares
−10.29K
Price / share
$3.81
Trade value
$39.19K
% of position
4.4%
2/23/2026
235.26K→224.98K
Class A Common Stock
Direct
Shares
−11.24K
Price / share
$3.66
Trade value
$41.13K
% of position
5.0%
2/24/2026
224.98K→213.74K
Total
Net shares
−21.53K
Net value
-$80.33K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 2/23/2026 | S · Sale | −10.29K | $3.81 | $39.19K | 4.4% | 235.26K | 224.98K |
| Class A Common Stock Direct | 2/24/2026 | S · Sale | −11.24K | $3.66 | $41.13K | 5.0% | 224.98K | 213.74K |
| Total | −21.53K | -$80.33K | ||||||
Derivative Transactions0
No derivative transactions reported